What is the most common extra-articular manifestation of rheumatoid arthritis?

Explanation

## Correct Answer: B. Subcutaneous nodule Rheumatoid nodules are the most common extra-articular manifestation of RA, occurring in 20–30% of RA patients in India and globally. These are firm, subcutaneous nodules typically found over pressure points (elbows, fingers, Achilles tendon) and represent granulomatous inflammation with central fibrinoid necrosis surrounded by palisading histiocytes and fibroblasts. Nodule formation is strongly associated with **RF (rheumatoid factor) positivity** and **anti-CCP antibodies**, indicating more aggressive disease. Histologically, they are identical to rheumatoid nodules seen in rheumatoid pneumoconiosis (Caplan syndrome). The presence of nodules correlates with worse prognosis, higher disease activity, and increased risk of other extra-articular manifestations. In Indian RA cohorts, nodules are documented as the single most frequent extra-articular finding, preceding or accompanying joint erosions. Their development is independent of disease duration but linked to RF seropositivity and immune dysregulation. Nodules may regress with effective DMARDs (methotrexate, biologics) but can persist despite remission. ## Why the other options are wrong **A. Vasculitis** — Vasculitis is a serious but **less common** extra-articular manifestation, occurring in only 5–10% of RA patients. It typically appears in advanced, long-standing seropositive disease and manifests as rheumatoid vasculitis affecting small and medium vessels, causing digital infarcts, leg ulcers, or mesenteric ischemia. While clinically significant and requiring urgent intervention, vasculitis is far less frequent than nodules and is not the 'most common' manifestation. **C. Felty's syndrome** — Felty's syndrome (RA + splenomegaly + neutropenia) is a **rare** extra-articular complication occurring in <1% of RA patients, typically in advanced seropositive disease with long duration. It represents immune-mediated destruction of neutrophils and requires specific investigation (CBC, imaging). The rarity and specificity of Felty's syndrome make it far less common than the ubiquitous rheumatoid nodule. **D. Sjogren's syndrome** — Secondary Sjögren's syndrome occurs in 10–15% of RA patients, making it more common than vasculitis or Felty's but still **less frequent than nodules**. While important for diagnosis (Schirmer test, anti-SSA/SSB antibodies), secondary Sjögren's is a distinct autoimmune overlap rather than a direct manifestation of RA pathology. Nodules remain the single most common extra-articular finding. ## High-Yield Facts - **Rheumatoid nodules** occur in 20–30% of RA patients and are the most common extra-articular manifestation. - Nodule formation is strongly associated with **RF positivity** and **anti-CCP antibodies**, indicating seropositive aggressive disease. - Histology: **fibrinoid necrosis** with **palisading histiocytes**; identical to nodules in Caplan syndrome (silicosis + RA). - Location: pressure points—**elbows, fingers, Achilles tendon, occiput**. - Nodules correlate with **worse prognosis, higher disease activity, and increased risk of erosions**. - Vasculitis (5–10%), Felty's (<1%), and secondary Sjögren's (10–15%) are all less common than nodules. ## Mnemonics **Extra-Articular RA by Frequency (VFNS)** **V**asculitis (5–10%) → **F**elty's (<1%) → **N**odules (20–30%) → **S**jögren's (10–15%). Remember: Nodules are MOST common, Felty's is RAREST. **Rheumatoid Nodule Locations (PEAFO)** **P**ressure points, **E**lbows, **A**chilles, **F**ingers, **O**cciput. Think: nodules form where skin rubs or bears weight. ## NBE Trap NBE may pair "vasculitis" with "serious complication" to lure students into choosing it as the "most important" rather than "most common" extra-articular manifestation. Frequency ≠ severity; nodules are common but benign, while vasculitis is rare but dangerous. ## Clinical Pearl In Indian RA clinics, rheumatoid nodules are often the first sign that prompts RF/anti-CCP testing and RA diagnosis, especially in rural populations presenting late. Their presence mandates aggressive DMARD therapy (methotrexate ± biologics) to prevent joint erosions and systemic complications. _Reference: Robbins Ch. 5 (Rheumatoid Arthritis); Harrison Ch. 313 (Rheumatoid Arthritis); Park's Textbook of Preventive and Social Medicine (epidemiology of RA in India)_